Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

The full indication for vilobelimab is as a treatment for adult patients with SARS‑CoV-2‑induced ARDS who are receiving ...

The European Medicines Agency re-examined clinical data of a subset of patients with one or no copies of the APOE4 gene ...

The drawbacks of retinoids involve the potential for irritancy, which can be concentration- and vehicle-dependent.

Over 30 years, Cortes has led or co-authored hundreds of studies, including many trials of landmark drugs to treat chronic ...

Deprescription and the prevention of hospitalization should be priorities, rather than aggressive management, a family ...

Increased exposure to fine particulate matter during pregnancy significantly increased the likelihood of having a spontaneous ...

Evidence-based smoking cessation treatment within 6 months of a cancer diagnosis yielded the largest survival benefit, ...

For decades, no-show patients have proven to be a costly problem for physicians. In fact, missed appointments lead to a ...

Women with PCOS have longer interconception periods, are of advanced maternal age, and have higher nulliparity and lower ...

Parents often worry that their child is a poor eater, so health professionals need to know what's normal and when ...

Socioeconomic and educational disparities significantly affect the access of women to cancer screening and care in Europe.